Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Transfusion. 2019 Sep;59(9):2776-2782. doi: 10.1111/trf.15422. Epub 2019 Jun 26.
Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridioides difficile infection and is potentially beneficial in other microbiota-related disorders. The provision of FMT in routine clinical practice requires an extensive infrastructure that is reliant on voluntary donors. Alongside an increasing demand for FMT, the logistic barriers of a large-scale donor-dependent operation and the difficulties among health authorities to regulate FMT limit the dissemination of sustainable FMT services. Blood centers are large organizations that handle a multitude of donor-dependent operations on a daily basis. Blood and feces share many of the same dependencies, and feces may present a new opportunity for the blood services to handle. In this paper, we describe how an FMT service may be established and embedded within the blood service infrastructure, and we explain the benefits of using blood donors as feces donors. We further explore the current indications of FMT, the challenges related to the lack of legislation, and the future perspectives for blood banks to meet a new and increasing demand.
粪便微生物群移植(FMT)是治疗复发性艰难梭菌感染的有效方法,并且可能对其他与微生物群相关的疾病有益。常规临床实践中提供 FMT 需要广泛的基础设施,该基础设施依赖于自愿供体。随着对 FMT 的需求不断增加,大规模依赖供体的操作的后勤障碍以及卫生当局在规范 FMT 方面的困难限制了可持续 FMT 服务的传播。血液中心是大型组织,每天都要处理多种依赖供体的操作。血液和粪便有许多共同的依赖性,粪便可能为血液服务提供了一个新的处理机会。在本文中,我们描述了如何在血液服务基础设施内建立和嵌入 FMT 服务,并解释了使用血液供体作为粪便供体的好处。我们进一步探讨了 FMT 的当前适应证、缺乏立法相关的挑战,以及未来血库满足新的和不断增长的需求的前景。